Icagen enters into Collaboration to Develop and Commercialize Therapy for Neurological Diseases Read more
Momenta Pharmaceuticals Provides Update on US Regulatory Strategy for M923, Proposed Biosimilar to HUMIRA Read more
Novartis advances ligelizumab (QGE031) in urticaria to Phase III on basis of strong Phase II head-to-head data Read more
Pluristem Therapeutics Enters into Cell Thawing Device License Agreement with Chart Industries Read more
Scientist.com Partners with Allele Biotech to Discover and Develop Therapeutic Nanoantibodies Read more